BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26988917)

  • 1. eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells.
    Lee JY; Kim HJ; Rho SB; Lee SH
    Oncotarget; 2016 Apr; 7(14):18541-57. PubMed ID: 26988917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma.
    Wang C; Jin G; Jin H; Wang N; Luo Q; Zhang Y; Gao D; Jiang K; Gu D; Shen Q; Huo X; Hu F; Ge T; Zhao F; Chu W; Shu H; Yao M; Cong W; Qin W
    Oncotarget; 2015 Feb; 6(5):2903-16. PubMed ID: 25609201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PACAP inhibits tumor growth and interferes with clusterin in cervical carcinomas.
    Lee JH; Lee JY; Rho SB; Choi JS; Lee DG; An S; Oh T; Choi DC; Lee SH
    FEBS Lett; 2014 Dec; 588(24):4730-9. PubMed ID: 25451228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA-directed clusterin silencing promotes cisplatin antitumor activity in human non-small cell lung cancer xenografts in immunodeficient mice.
    Zhang B; Liu ZM; Hao FG; Wang M
    Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1595-601. PubMed ID: 24943969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer.
    Niu Z; Li X; Hu B; Li R; Wang L; Wu L; Wang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Dec; 44(12):991-8. PubMed ID: 23099883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo.
    Ma G; Cai H; Gao L; Wang M; Wang H
    World J Surg Oncol; 2015 Feb; 13():80. PubMed ID: 25884382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clusterin, a Novel DEC1 Target, Modulates DNA Damage-Mediated Cell Death.
    Ming X; Bao C; Hong T; Yang Y; Chen X; Jung YS; Qian Y
    Mol Cancer Res; 2018 Nov; 16(11):1641-1651. PubMed ID: 30002194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer.
    Bhutia SK; Das SK; Kegelman TP; Azab B; Dash R; Su ZZ; Wang XY; Rizzi F; Bettuzzi S; Lee SG; Dent P; Grant S; Curiel DT; Sarkar D; Fisher PB
    J Cell Physiol; 2012 May; 227(5):1805-13. PubMed ID: 21732348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GRP78 regulates clusterin stability, retrotranslocation and mitochondrial localization under ER stress in prostate cancer.
    Li N; Zoubeidi A; Beraldi E; Gleave ME
    Oncogene; 2013 Apr; 32(15):1933-42. PubMed ID: 22689054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor α promotes protein synthesis by fine-tuning the expression of the eukaryotic translation initiation factor 3 subunit f (eIF3f).
    Cuesta R; Berman AY; Alayev A; Holz MK
    J Biol Chem; 2019 Feb; 294(7):2267-2278. PubMed ID: 30573685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F.
    Esteves P; Dard L; Brillac A; Hubert C; Sarlak S; Rousseau B; Dumon E; Izotte J; Bonneu M; Lacombe D; Dupuy JW; Amoedo N; Rossignol R
    Oncogene; 2020 Jan; 39(3):617-636. PubMed ID: 31527668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells.
    Shi J; Kahle A; Hershey JW; Honchak BM; Warneke JA; Leong SP; Nelson MA
    Oncogene; 2006 Aug; 25(35):4923-36. PubMed ID: 16532022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer.
    Wei L; Xue T; Wang J; Chen B; Lei Y; Huang Y; Wang H; Xin X
    Int J Cancer; 2009 Aug; 125(4):791-806. PubMed ID: 19391138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear clusterin accumulation during heat shock response: implications for cell survival and thermo-tolerance induction in immortalized and prostate cancer cells.
    Caccamo AE; Desenzani S; Belloni L; Borghetti AF; Bettuzzi S
    J Cell Physiol; 2006 Apr; 207(1):208-19. PubMed ID: 16331665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-secreted clusterin isoforms are translated in rare amounts from distinct human mRNA variants and do not affect Bax-mediated apoptosis or the NF-κB signaling pathway.
    Prochnow H; Gollan R; Rohne P; Hassemer M; Koch-Brandt C; Baiersdörfer M
    PLoS One; 2013; 8(9):e75303. PubMed ID: 24073260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. eIF3f depletion impedes mouse embryonic development, reduces adult skeletal muscle mass and amplifies muscle loss during disuse.
    Docquier A; Pavlin L; Raibon A; Bertrand-Gaday C; Sar C; Leibovitch S; Candau R; Bernardi H
    J Physiol; 2019 Jun; 597(12):3107-3131. PubMed ID: 31026345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel nucleolar localization of clusterin and its associated functions in human oral cancers: An in vitro and in silico analysis.
    Kadam R; Harish M; Dalvi K; Teni T
    Cell Biochem Funct; 2021 Apr; 39(3):380-391. PubMed ID: 33155695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells.
    Zhong B; Sallman DA; Gilvary DL; Pernazza D; Sahakian E; Fritz D; Cheng JQ; Trougakos I; Wei S; Djeu JY
    Mol Cancer Ther; 2010 Jun; 9(6):1831-41. PubMed ID: 20501799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein.
    Criswell T; Klokov D; Beman M; Lavik JP; Boothman DA
    Cancer Biol Ther; 2003; 2(4):372-80. PubMed ID: 14508108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose IR-induced IGF-1-sCLU expression: a p53-repressed expression cascade that interferes with TGFβ1 signaling to confer a pro-survival bystander effect.
    Klokov D; Leskov K; Araki S; Zou Y; Goetz EM; Luo X; Willson D; Boothman DA
    Oncogene; 2013 Jan; 32(4):479-90. PubMed ID: 22391565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.